About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05860959

SUBLOCADE Long-term Outcomes

This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic facto...

Lead sponsor: Indivior Inc.•35 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Indivior Inc.

This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participants must meet all of the following criteria:
•Is an adult ≥ 18 years of age who has signed the informed consent form
•Plans to receive additional SUBLOCADE injections and
•* Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
•* OR
•* Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
•Is not currently participating in any clinical trial requiring medical intervention
•Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence

Related studies

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1

NCT07549126 · Opioid Use Disorder, Clinical Decision Support

RECRUITINGEARLY Phase 1

Cannabidiol in Opioid Use Disorder and Chronic Pain

NCT04587791 · Chronic Pain, Opioid Use Disorder

RECRUITINGEARLY Phase 1

Pilot of Mailing Buprenorphine

NCT07421102 · Opioid Use Disorder

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

NCT05492825 · Substance Use Disorders, Chronic Pain, and more

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

NCT05942313 · Opioid Use Disorder, Pregnancy Related

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 16, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment480

Start dateAug 2023

Last updatedOct 16, 2025

Condition

Opioid Use Disorder

Locations shown

ATP Clinical Research

Costa Mesa, California

Neighborhood Healthcare-Institute of Health

Escondido, California

Elevate Health and Wellness

Westport, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 16, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions